274
Last Update Posted: 2017-01-12
Recruiting has ended
All Genders accepted | 18 Years-45 Years |
60 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9
The purpose of this study is to evaluate the safety and efficacy of flupenthixol and haloperidol for cocaine dependence in individuals with schizophrenia/schizoaffective illness.
Eligibility
Relevant conditions:
Cocaine-Related Disorders
Substance-Related Disorders
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov